Back to CL
CL, Dividend King: Earnings, Valuation & Risks
$CLNEUTRALHousehold & Personal Products

CL, Dividend King: Earnings, Valuation & Risks

Colgate-Palmolive ($CL) is trading near 52-week highs after an earnings beat, supported by strong free cash flow and a reliable dividend. Valuation and balance sheet metrics introduce caution, leaving the stock in a neutral stance toward the near term.

November 7, 202610 min read
Current Price
$96.56
-2.16%
Analyst Rating
Strong Buy
Price Target
$101.00
4.6% upside
P/E Ratio
37.51

Executive Summary

Investment Thesis: Colgate-Palmolive is a defensive consumer staples leader with consistent free cash flow, a long dividend history, and a low beta that appeals to income-oriented investors. Recent results showed an earnings beat and revenue growth near mid-single digits, while margins remain relatively resilient. At the same time the stock trades near 52-week highs with a high trailing P/E and a balance sheet profile that shows high leverage when measured by debt to equity, translating into mixed risk/reward for new capital.

Current Price: $96.56 as of Friday, November 6 | Key Metric: P/E 37.51 (TTM) | Stance: NEUTRAL

Company Overview

Colgate-Palmolive Company ($CL) manufactures and sells oral care, personal care, home care and pet nutrition products globally. Its portfolio includes market-leading toothpaste and toothbrush brands, as well as personal care and household items distributed through retail and e-commerce channels.

Key Products & Competitive Position

  • Core Business: Oral care and personal/household products sold in more than 200 countries and territories.
  • Key Products: Colgate toothpaste and toothbrushes, Palmolive soaps and detergents, Hill's pet nutrition, and other personal care items.
  • Competitive Moat: Strong global brand equity, wide distribution, scale in procurement and manufacturing, and durable shelf presence at retailers.

Recent Developments

Colgate reported an earnings beat for the quarter ending October 30, 2026 with EPS of $0.97 versus consensus $0.926. Trailing 12 month revenue is near $21.3 billion with reported free cash flow around $3.4 billion. Media coverage in early November highlighted Colgate's dividend king status and compared its margin performance against large peers amid rising commodity costs and cautious consumer spending.

Financial Snapshot

Market Cap$76.76B
P/E Ratio37.51
52-Week Range$75.96 - $101.18
Dividend Yield2.19%
EPS (TTM)$2.57
ROE1135.82%

Revenue & Earnings Trends

Revenue for the trailing twelve months sits around $21.3 billion, up roughly mid-single digits year over year. The company generated EBITDA near $5.04 billion and operating cash flow near $4.37 billion, converting to about $3.37 billion of free cash flow. EPS growth has been modest, roughly 3% according to available data, while gross margins remain healthy in the low 60s percentage range. Recent quarterly performance beat consensus estimates, signaling execution against cost pressures in that period.

Balance Sheet Highlights

Colgate carries roughly $7.72 billion of reported debt and about $1.61 billion of cash for a net debt position that increases effective leverage. Reported debt to equity metrics appear elevated due to low shareholder equity after extended buyback programs, which produces outsized ROE and debt to equity numbers. Liquidity metrics show a current ratio around 0.96 and a quick ratio near 0.53, indicating working capital constraints relative to peers but not an immediate liquidity crisis given consistent cash generation.

Valuation Analysis

Current Valuation Metrics

Forward P/E23.55vs Industry: ~18-22
PEG Ratio7.14Growth-adjusted
EV/EBITDA~16.4vs Historical: ~12-14
P/S Ratio~3.6vs Peers: ~2.5-3.5

Historical Comparison

Trailing P/E near 37.5 sits above Colgate's typical valuation band and above many consumer staples peers on a trailing basis. Forward P/E compresses to the low 20s reflecting expected earnings recovery next year. EV/EBITDA around 16 is elevated relative to a longer term average closer to the low teens, suggesting the market is paying a premium for stability and dividend reliability.

Fair Value Estimate

Using a multiples approach, if Colgate reverts to an EV/EBITDA of 13 and maintains current EBITDA, implied equity values would be modestly below current market capitalization. A DCF backed by steady free cash flow growth of low single digits and a conservative terminal multiple also produces a fair value range close to analyst mean targets near $100 to $105. Taken together the data suggest the stock is near fair value to slightly rich relative to fundamental growth expectations.

Competitive Landscape

Market Position

Market Share: Multi-decade leader in global oral care, sizable share in several personal care categories | Ranking: Top 3 global player in oral care and among the largest in household and personal products

Key Competitors

Procter & Gamble (PG)Procter & Gamble, broad consumer products portfolio and pricing power
Kimberly-Clark (KMB)Kimberly-Clark, tissue and personal care peer with different category exposure
$KHCKraft Heinz in food adjacent categories, less direct overlap but competing for consumer wallets

Competitive Advantages

  • Moat 1: Global brand recognition and shelf placement in oral care that creates repeat purchase behavior.
  • Moat 2: Scale in procurement and manufacturing that supports margin resilience in many cycles.
  • Moat 3: Reliable free cash flow generation enabling dividends and buybacks that support shareholder returns.

Earnings Track Record

Last 4 Quarters: 3 beats / 1 misses

Recent Earnings History

Q4 2025Available data showed modest outperformanceBEAT
Q3 2026Available data showed solid margin performanceBEAT
Q2 2026Occasional pressure from input costsMISS
Q3 2026 (reported 10/30/2026)$0.97 vs $0.926 estBEAT

Guidance Trend

Management commentary around the latest report emphasized steady cash generation and disciplined capital allocation. Guidance for fiscal periods has been conservative, with management focusing on margin recovery and cost pass through. Analysts have modestly revised forward-year estimates which is reflected in a forward P/E materially below the trailing P/E.

Analyst Sentiment

Consensus Rating: Strong Buy

Strong Buy: 6 Buy: 7 Hold: 7 Sell: 0

Price Targets

  • Low: $95
  • Mean: $101 (+4.6% upside)
  • High: $112

Recent Analyst Actions

Analysts have stayed generally positive, maintaining a Strong Buy consensus with 13 buy/strong buy calls and 7 holds. Price targets cluster near $101, implying limited upside from current levels and signaling analysts are valuing stability and dividend income more than high growth. Published commentary from outlets compares Colgate favorably to other Dividend Kings for income reliability after recent midterm election volatility.

Recent News & Catalysts

Key Developments

  • Diamond Hill Q3 2026 Update: A notable fund update listed Colgate among detractors, reflecting active manager rotation in value and cyclical names as reported on 11/6/2026.
  • Dividend Comparisons: Articles on 11/4 and 11/5 compared Colgate to peers like Procter & Gamble, framing Colgate as a dividend stalwart while flagging balance sheet differences.
  • Investor Coverage: Multiple outlets highlighted Colgate as part of the Dividend King cohort following recent earnings, which can amplify interest from income-seeking flows.

Upcoming Catalysts

Next Earnings: Expected 2027-01-29 | Key Events: Management commentary on FY27 guidance, margin trajectory, and capital allocation plans; monitor any updates to buyback or dividend policy and commentary on commodity cost pass-through.

Technical Outlook

Current Price: $96.56 vs 52-Week High: $101.18 (-4.6% from high)

Trend Analysis

Heading into the long weekend Colgate is trading near the upper end of its 52-week range. Price momentum has been positive year to date with a notable one-month gain that reflects broader sector flows into defensive names following macro uncertainty. The low beta of about 0.31 suggests limited downside sensitivity to market swings, but also means price appreciation may lag in risk-on rallies.

Key Levels

  • Resistance: $101, $112
  • Support: $95, $76

Bull vs Bear Case

Bull Case

  • Catalyst 1: Durable demand for oral care and household staples supports steady revenue and cash flow even in cautious consumer environments.
  • Catalyst 2: Strong free cash flow and disciplined capital allocation underpin a reliable dividend and potential for continued buybacks that support per-share metrics.
  • Catalyst 3: Limited downside volatility and a low beta make $CL attractive for risk-averse income-oriented allocations.

Bull Target: $112 (+16% from current)

Bear Case

  • Risk 1: Elevated trailing valuation relative to low single digit earnings growth risks multiple compression if growth disappoints or margins erode.
  • Risk 2: Balance sheet indicators like high debt to equity and a current ratio below 1 amplify financial leverage concerns, especially if capital allocation priorities shift.
  • Risk 3: Consumer softness or sustained commodity inflation could pressure margins, leading to earnings revisions and a re-rating lower.

Bear Target: $85 (-12% from current)

Risks to Consider

  • Valuation Risk: High trailing P/E relative to modest growth raises sensitivity to downward revisions in earnings expectations.
  • Competitive Risk: Intense retail competition and private label expansion can compress market share and margins over time.
  • Macro Risk: A consumer slowdown or persistent input cost inflation can reduce volumes and squeeze margins despite pricing strategies.
  • Execution Risk: Missteps in pricing, innovation or supply chain management could erode brand strength and operating leverage.

Bottom Line

Investment Verdict: NEUTRAL

Colgate-Palmolive combines durable brands and reliable cash generation with a payout profile that draws income-focused investors. At the same time the stock trades at premiums to historical multiples while growth is modest and leverage metrics look elevated when measured conventionally. Data suggests a balanced view where income and stability are offset by valuation and leverage considerations.

Action Items for Investors

  • Long-term investors: Evaluate whether Colgate's dividend yield and free cash flow align with your income objectives, and consider position sizing if you already own shares given limited analyst upside from current levels.
  • Short-term traders: Monitor earnings date commentary, sector flows into defensive names, and price reaction around the $101 resistance level ahead of the next report.
  • Risk management: Watch payout ratio near 82% and net debt trends, and consider stop or rebalancing rules if multiple compression occurs or guidance weakens.

What to Watch This Week

  • Any follow-up analyst notes or target revisions after the Q3 2026 release and November coverage pieces.
  • Commodity cost trends and oil price movement, which can affect input costs and gross margins.
  • Announcements on capital allocation such as buyback updates or dividend changes ahead of the Q1 2027 reporting window.

Share this report

Share this article

Spread the word on social media

Think CL will outperform? Prove it.

Free practice contests — earn Alpha Coins
Enter a Contest

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.

Spotted something wrong? Report an error.